CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831381173
- Phone
- (206) 701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-07 | Wyrick Susan D. See Remarks | Option exercise | +3,250 | 200,583 | ||
| 2026-03-07 | Wyrick Susan D. See Remarks | Option exercise · Restricted Stock Units | −3,250 | 6,500 | ||
| 2026-03-06 | Harr Steve President & CEO | Option exercise | +41,666 | 7,918,596 | ||
| 2026-03-06 | Harr Steve President & CEO | Option exercise · Restricted Stock Units | −41,666 | 125,001 | ||
| 2026-03-06 | Wyrick Susan D. See Remarks | Option exercise | +10,416 | 197,333 | ||
| 2026-03-06 | Wyrick Susan D. See Remarks | Option exercise · Restricted Stock Units | −10,416 | 31,251 | ||
| 2026-03-05 | Harr Steve President & CEO | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2026-03-05 | Harr Steve President & CEO | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2026-03-05 | Wyrick Susan D. See Remarks | Grant or award · Restricted Stock Units | +45,833 | 45,833 | ||
| 2026-03-05 | Wyrick Susan D. See Remarks | Grant or award · Stock Option (Right to Buy) | +206,250 | 206,250 | ||
| 2026-03-03 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −491 | $3.91 | $2K | 186,917 |
| 2026-03-02 | Wyrick Susan D. See Remarks | Option exercise | +1,525 | 187,408 | ||
| 2026-03-02 | Wyrick Susan D. See Remarks | Option exercise · Restricted Stock Units | −1,525 | 1,525 | ||
| 2026-02-17 | Piper Brian EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2026-02-17 | Piper Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2026-01-05 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −2,407 | $4.27 | $10K | 185,883 |
| 2026-01-05 | Bishop Hans Edgar Director | Grant or award | +6,157 | 5,840,740 | ||
| 2026-01-02 | Wyrick Susan D. See Remarks | Option exercise | +7,500 | 188,290 | ||
| 2026-01-02 | Wyrick Susan D. See Remarks | Option exercise · Restricted Stock Units | −7,500 | 0 | ||
| 2025-12-15 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −873 | $5.22 | $5K | 180,790 |
Page 2 of 9 · 172 trades